PRF Technologies (PRFX) Long-Term Investments (2022 - 2025)
PRF Technologies' (PRFX) quarterly Long-Term Investments came in at $7.6 million in Q4 2025, up 7783.51% YoY from $97000.0 in Q4 2024, and up 5.43% on a QoQ basis from $7.3 million in Q2 2025.
PRF Technologies (PRFX) Long-Term Investments (2022 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 4 years of Long-Term Investments data on file, last reported at $7.6 million in Q4 2025.
- Quarterly Long-Term Investments rose 7783.51% year-over-year to $7.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.6 million (up 7783.51% YoY) and the FY2025 annual result came in at $7.6 million, up 7783.51% from the prior year.
- Long-Term Investments grew to $7.6 million in Q4 2025, from $7.3 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $7.6 million in Q4 2025 to a low of $44000.0 in Q4 2022.
- A 4-year average of $2.5 million and a median of $123000.0 in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2024 — Long-Term Investments dropped 25.95% — and 2025, when it surged 7783.51%.
- Tracing PRFX's Long-Term Investments over 4 years: stood at $44000.0 in 2022, then surged by 197.73% to $131000.0 in 2023, then retreated by 25.95% to $97000.0 in 2024, then surged by 7783.51% to $7.6 million in 2025.
- The last three Long-Term Investments figures came in at $7.6 million (Q4 2025), $7.3 million (Q2 2025), and $97000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 60.00 Mn |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - | 7.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.65 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Dec 31, 2024 | 97,000.00 |
| Jun 30, 2024 | 115,000.00 |
| Dec 31, 2023 | 131,000.00 |
| Dec 31, 2022 | 44,000.00 |